Staff View: Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative

Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative

Metformin has been known to the mankind for centuries. Metformin is the first line of drug of choice for the treatment of type 2 diabetes. Initial pharmaceutical therapy was for treating the frequent urinal problem which is a primary manifestation of diabetes. At the time of writing, metformin as an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Prabhakaran, Sonia, Thirumal , Dhiviya, Jolius, Gimbun, Ranganathan, Balu
Format:	Article
Language:	English
Published:	Informatics Publishing Limited 2017
Subjects:	TP Chemical technology
Online Access:	http://umpir.ump.edu.my/id/eprint/20659/1/Metformin%20-%20A%20Panacea%20Pharmaceutical%20Agent%20through%20convergence-fkksa-2017.pdf http://umpir.ump.edu.my/id/eprint/20659/ http://www.informaticsjournals.com/index.php/jnr/article/view/17938
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my.ump.umpir.20659
record_format	eprints
spelling	my.ump.umpir.206592018-03-01T05:25:31Z http://umpir.ump.edu.my/id/eprint/20659/ Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative Prabhakaran, Sonia Thirumal , Dhiviya Jolius, Gimbun Ranganathan, Balu TP Chemical technology Metformin has been known to the mankind for centuries. Metformin is the first line of drug of choice for the treatment of type 2 diabetes. Initial pharmaceutical therapy was for treating the frequent urinal problem which is a primary manifestation of diabetes. At the time of writing, metformin as an intervention is looked into for cardiovascular risks, polycystic ovary syndrome and breast cancer. Annual demand for Metformin is 23,000 Metric tons per annum. Nano Drug Delivery Systems (NDDS) has embarked into Metformin controlled and targeted delivery for breast cancer, pancreatic cancer and non-small cell lung cancer. Clinical estimation of the biological fluids by the FDA approved diagnostic laboratories use LC-MS/MS where blood samples estimate Metformin as an intact molecule easing the pressure of clinical trials result. Metformin was manufactured by a less known and low profile Aoron pharmaceutical, France not aware of the block buster drug hence the potential of technology development start-ups can neither be underwritten nor underestimated even when there is a very high rate (~90%) of failed biotech/biomed start-up ventures. The bloom of the French lilac (metformin) to blossom and flower for the cure of breast cancer by convergence revolution initiative with the integration of academia, hospital, technology business incubator, multinational corporation with the deliverance of a start-up company Informatics Publishing Limited 2017 Article PeerReviewed application/pdf en cc_by http://umpir.ump.edu.my/id/eprint/20659/1/Metformin%20-%20A%20Panacea%20Pharmaceutical%20Agent%20through%20convergence-fkksa-2017.pdf Prabhakaran, Sonia and Thirumal , Dhiviya and Jolius, Gimbun and Ranganathan, Balu (2017) Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative. Journal of Natural Remedies, 17 (3). pp. 69-79. ISSN 2320-3358 http://www.informaticsjournals.com/index.php/jnr/article/view/17938
institution	Universiti Malaysia Pahang
building	UMP Library
collection	Institutional Repository
continent	Asia
country	Malaysia
content_provider	Universiti Malaysia Pahang
content_source	UMP Institutional Repository
url_provider	http://umpir.ump.edu.my/
language	English
topic	TP Chemical technology
spellingShingle	TP Chemical technology Prabhakaran, Sonia Thirumal , Dhiviya Jolius, Gimbun Ranganathan, Balu Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
description	Metformin has been known to the mankind for centuries. Metformin is the first line of drug of choice for the treatment of type 2 diabetes. Initial pharmaceutical therapy was for treating the frequent urinal problem which is a primary manifestation of diabetes. At the time of writing, metformin as an intervention is looked into for cardiovascular risks, polycystic ovary syndrome and breast cancer. Annual demand for Metformin is 23,000 Metric tons per annum. Nano Drug Delivery Systems (NDDS) has embarked into Metformin controlled and targeted delivery for breast cancer, pancreatic cancer and non-small cell lung cancer. Clinical estimation of the biological fluids by the FDA approved diagnostic laboratories use LC-MS/MS where blood samples estimate Metformin as an intact molecule easing the pressure of clinical trials result. Metformin was manufactured by a less known and low profile Aoron pharmaceutical, France not aware of the block buster drug hence the potential of technology development start-ups can neither be underwritten nor underestimated even when there is a very high rate (~90%) of failed biotech/biomed start-up ventures. The bloom of the French lilac (metformin) to blossom and flower for the cure of breast cancer by convergence revolution initiative with the integration of academia, hospital, technology business incubator, multinational corporation with the deliverance of a start-up company
format	Article
author	Prabhakaran, Sonia Thirumal , Dhiviya Jolius, Gimbun Ranganathan, Balu
author_facet	Prabhakaran, Sonia Thirumal , Dhiviya Jolius, Gimbun Ranganathan, Balu
author_sort	Prabhakaran, Sonia
title	Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
title_short	Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
title_full	Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
title_fullStr	Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
title_full_unstemmed	Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
title_sort	metformin - a panacea pharmaceutical agent through convergence revolution initiative
publisher	Informatics Publishing Limited
publishDate	2017
url	http://umpir.ump.edu.my/id/eprint/20659/1/Metformin%20-%20A%20Panacea%20Pharmaceutical%20Agent%20through%20convergence-fkksa-2017.pdf http://umpir.ump.edu.my/id/eprint/20659/ http://www.informaticsjournals.com/index.php/jnr/article/view/17938
_version_	1643668934231064576
score	13.211869

Metformin - A Panacea Pharmaceutical Agent through convergence revolution initiative

Similar Items